Current Ratio in % of Ikena Oncology, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ikena Oncology, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2025.
  • Ikena Oncology, Inc. Current Ratio for the quarter ending September 30, 2025 was 846 %, a 43.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Ikena Oncology, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 846 -663 -43.9% Sep 30, 2025
Q2 2025 869 -461 -34.7% Jun 30, 2025
Q1 2025 968 -292 -23.2% Mar 31, 2025
Q4 2024 1.04K -110 -9.56% Dec 31, 2024
Q3 2024 1.51K +516 +52% Sep 30, 2024
Q2 2024 1.33K +448 +50.8% Jun 30, 2024
Q1 2024 1.26K +498 +65.3% Mar 31, 2024
Q4 2023 1.15K +396 +52.7% Dec 31, 2023
Q3 2023 993 +211 +26.9% Sep 30, 2023
Q2 2023 882 +72.9 +9% Jun 30, 2023
Q1 2023 762 -94.3 -11% Mar 31, 2023
Q4 2022 750 -129 -14.7% Dec 31, 2022
Q3 2022 782 -29.6 -3.65% Sep 30, 2022
Q2 2022 810 Jun 30, 2022
Q1 2022 856 Mar 31, 2022
Q4 2021 879 Dec 31, 2021
Q3 2021 812 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.